YTHDF1 and neoplasm: Further study showed that the efficacy of combined YTHDF1 knockdown and anti-PD-L1 treatment was quite good, superior to that of single agent control group, and combining m6A with immune checkpoint inhibitor (ICI) treatment is promising in tumor therapy.